Drug Profile
Candesartan cilexetil/pioglitazone
Alternative Names: TCV-116/Actos; TCV-116/pioglitozoneLatest Information Update: 09 Nov 2010
Price :
$50
*
At a glance
- Originator Takeda
- Class Antihyperglycaemics; Antihypertensives; Benzimidazoles; Tetrazoles; Thiazolidinediones
- Mechanism of Action Angiotensin type 1 receptor antagonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension in diabetes
Most Recent Events
- 12 May 2010 Discontinued - Phase-III for Hypertension in diabetes in Japan (PO)